Issue Date: March 27, 2017
Academic drug discovery centers adapt to shifts in funding sources
Craig Lindsley flew out to Tulsa in November 2012 to give a talk about the research in his labs at the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD) in Nashville. His host was William K. Warren Jr., a businessperson and philanthropist who had endowed the medicinal chemist’s chair at Vanderbilt University.
Lindsley walked his audience through what was then a six-year effort to develop compounds that address the cognitive challenges and tough-to-treat symptoms of schizophrenia. . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society